Home › Headache › NCT07477236
MyVitalC: Sleep and Everyday Headache Management
A Real-World, Single-Arm Observational Study Evaluating the Effects of MyVitalC (ESS60 in Extra Virgin Olive Oil) on Sleep Disturbance and Everyday Headaches
Who can join
All ages · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Adults of legal age of consent * Able to provide informed consent * Willing to complete weekly assessments and daily logs * Able to purchase and use the study product Exclusion Criteria: * Have known allergies to olive oil or product components * Are pregnant or breastfeeding * Have severe or chronic headache disorders * Have significant gastrointestinal conditions * Have medical conditions that could be exacerbated by supplement use * Have concerns about dizziness, fatigue, or mood disturbances * Are subject to organizational or legal restrictions on supplement use
About the study
Sleep disturbance and recurring headaches can negatively affect daily functioning, mood, and productivity. MyVitalC (ESS60 in extra virgin olive oil) is a commercially available dietary supplement that has generated anecdotal claims related to sleep quality and headache relief; however, human data remain limited.
This real-world observational study is designed to help participants evaluate whether use of MyVitalC is associated with changes in sleep disturbance and headache frequency or severity in their own daily lives. Participants will complete a four-week baseline observation period without the intervention, followed by six weeks of daily MyVitalC use, with weekly self-reported assessments. Participants serve as their own control, allowing for within-person comparison of outcomes before and during product use.
What is being tested
- MyVitalC (ESS60 in Extra Virgin Olive Oil) (dietary supplement)
Sponsor: Efforia, Inc · Participants: 100 · Started: Jan 24, 2026
Contact the study team
- Matthew Amsden · Phone: (646) 679-2479
Official record on ClinicalTrials.gov — NCT07477236
Locations in the U.S.
| New York | Efforia, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.